Physician profile
John P Forrest
NPI 1346808110
$3,303.89
in general payments reported to CMS, 2019-2025
16 companies · $685 in 2025
The $685 reported for 2025 was more than what 84% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $454 · 2020: $117 · 2021: $348 · 2022: $397 · 2023: $807 · 2024: $495 · 2025: $685.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,987.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,987.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $1,109.24 | 2022-2025 | Infuse, Biotrue One Day, Miebo |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $497.61 | 2019-2021 | |
| Alcon Vision LLC | $466.77 | 2021-2025 | Precision 1, Total30, Precision7 |
| Coopervision INC. | $317.48 | 2019-2025 | Myday Contact Lens, Clariti Contact Lens |
| Johnson & Johnson Vision Care, INC. | $217.00 | 2023-2024 | Acuvue |
| Optovue, INC. | $118.47 | 2019 | |
| Lkc Technologies, INC. | $116.52 | 2023 | |
| Sun Pharmaceutical Industries INC. | $111.08 | 2022-2025 | Cequa |
| Tarsus Pharmaceuticals, INC. | $96.82 | 2024-2025 | Xdemvy |
| Oasis Medical, INC. | $91.84 | 2019 | |
| Dompe US, INC. | $67.42 | 2025 | Oxervate |
| Abbvie INC. | $25.22 | 2022 | |
| Thea Pharma INC. | $20.44 | 2025 | Iyuzeh |
| Allergan, INC. | $18.99 | 2021 | |
| Biotissue Holdings INC. | $15.75 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $13.24 | 2023 | Tyrvaya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Forrest listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.